Journal
JOURNAL OF THE NEUROLOGICAL SCIENCES
Volume 245, Issue 1-2, Pages 137-140Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jns.2005.08.022
Keywords
multiple sclerosis; interferon beta; cognitive function; clinical trial
Categories
Ask authors/readers for more resources
Cognitive impairment in multiple sclerosis is frequent, but the effect of immunomodulating drugs and mainly interferon beta (IFNO) on the neuropsychological aspects of the disease has not been fully studied. The data that we have are not conclusive. This paper reviews the effect of IFN beta on cognition in the different clinical forms of the disease and the future directions of clinical trials. (c) 2006 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
